EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.220
March 31, 2026 -33.32
December 31, 2025 -134.61
September 30, 2025 -163.35
June 30, 2025 -165.64
March 31, 2025 -138.43
December 31, 2024 -39.91
September 30, 2024 -14.90
June 30, 2024 -16.50
March 31, 2024 -15.84
December 31, 2023 -16.35
September 30, 2023 -20.43
June 30, 2023 -18.98
March 31, 2023 -18.10
December 31, 2022 -18.99
September 30, 2022 -19.28
June 30, 2022 -22.07
Date Value
March 31, 2022 -25.86
December 31, 2021 -26.98
September 30, 2021 -26.08
June 30, 2021 -28.44
March 31, 2021 -28.05
December 31, 2020 -25.43
September 30, 2020 -25.20
June 30, 2020 -21.22
March 31, 2020 -19.99
December 31, 2019 -21.52
September 30, 2019 -17.43
June 30, 2019 -16.29
March 31, 2019 -13.12
December 31, 2018 -14.59
September 30, 2018 -10.92
June 30, 2018 -8.317
March 31, 2018 -6.958

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -103.95
Mereo BioPharma Group Plc -0.1752
BioNTech SE -7.847
Silence Therapeutics Plc -0.4231
Compass Pathways Plc -4.624